SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-117193
Filing Date
2016-05-03
Accepted
2016-05-03 21:28:13
Documents
2
Period of Report
2016-04-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13072
2 POA DOCUMENT poa.txt EX-24.4_651358 2852
  Complete submission text file 0001209191-16-117193.txt   17245
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
Smith Scott Andrew (Reporting) CIK: 0001614975 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34912 | Film No.: 161617231